During the last session, Mersana Therapeutics Inc (NASDAQ:MRSN)’s traded shares were 0.98 million, with the beta value of the company hitting 1.53. At the end of the trading day, the stock’s price was $2.16, reflecting an intraday loss of -4.00% or -$0.09. The 52-week high for the MRSN share is $6.28, that puts it down -190.74 from that peak though still a striking 62.96% gain since the share price plummeted to a 52-week low of $0.80. The company’s market capitalization is $264.30M, and the average trade volume was 1.61 million shares over the past three months.
Mersana Therapeutics Inc (MRSN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.44. MRSN has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mersana Therapeutics Inc (NASDAQ:MRSN) trade information
Mersana Therapeutics Inc (MRSN) registered a -4.00% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.00% in intraday trading to $2.16, hitting a weekly high. The stock’s 5-day price performance is 10.20%, and it has moved by 4.35% in 30 days. Based on these gigs, the overall price performance for the year is -39.83%.
Mersana Therapeutics Inc (MRSN) estimates and forecasts
Statistics show that Mersana Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Mersana Therapeutics Inc (MRSN) shares have gone down -20.30% during the last six months, with a year-to-date growth rate more than the industry average at 59.46% against 15.60.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 11.93%. While earnings are projected to return 58.18% in 2024.
MRSN Dividends
Mersana Therapeutics Inc is due to release its next quarterly earnings in August. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
